tirzepatide subcutaneous is a weekly injection, sold under the brand names Mounjaro (mainly for type 2 diabetes) and Zepbound (mainly for obesity). It works as a dual agent, activating both glucagon-like peptide-1 ( Comprehensive Guide To Subcutaneous Self-Injection

CrossRef Historical and cultural aspects of obesity: From a symbol of wealth and prosperity to the epidemic of the 21st century Marta Sumiska, Rafa Podgrski, Klaudia BoguszGrna, Bogda Skowroska, Artur Mazur, Marta Fichna Obesity Reviews.2022;[Epub] CrossRef Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, Hisayuki Katsuyama International Journal of Molecular Sciences.2022

Engineered extracellular vesicle-delivered CRISPR/Cas9 for radiotherapy sensitization of glioblastoma

Biocon Ltd strengthened focus on affordable biologics and metabolic healthcare solutions in Asia

Semaglutide Semaglutide is ideal for individuals looking for long-term weight management, particularly those with obesity, insulin resistance, or Type 2 diabetes

Even so, an October 2025 Gallup poll reported that 12.4% of respondents to a nationally representative survey were taking this class of medication for weight loss